Aducanumab: A Deep Dive into BIIB037 and its Impact A medication, initially known as BIIB037, is a complex attempt to combat early-stage Alzheimer's condition. Developed by Biogen, this molecule functions by clearing https://denisgate410980.pointblog.net/text-93125156